LUCID DIAGNOSTICS INC reports a Return on Equity (ROE) of -1,125.28%.

What is LUCD's dividend yield?

LUCID DIAGNOSTICS INC offers a dividend yield of 0.00%.

What is LUCD's Quality Score?

Our AI rates LUCD's overall financial quality at 31 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy LUCD?

Our AI Timing Score for LUCD is 27 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does LUCD belong to?

LUCID DIAGNOSTICS INC is classified under the Healthcare >> Medical Devices sector on the NASDAQ exchange

LUCD (NASDAQ) Stock Analysis | LUCID DIAGNOSTICS INC

Stock Check Daily update data at 8:30 AM
(Price: 2026-07-31 | FS: 2026-03-31)

LUCD AI Analysis Summary

Our AI summary for LUCD: LUCID DIAGNOSTICS INC (NASDAQ), Healthcare >> Medical Devices sector. The stock currently trades at a P/E of 0.00, ROE of -1,125.28%, a dividend yield of 0.00%. Its financial Quality Score stands at 31/100 — fundamentals below the market average. The AI Timing Score is 27/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

LUCD

LUCID DIAGNOSTICS INC

US:NASDAQ STOCK Healthcare >> Medical Devices

USD 0.87

-0.03 (-3.28%) Day Change

Watchlist Portfolio Compare Chart

6.53

D/E

-1,125.3%

ROE

-132.1%

ROA

0.00%

Div Yield

LUCID DIAGNOSTICS INC
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 0.87 Price -0.03 (-3.28%) Day Change	NEWS SCORE: N/A

LUCD, the overall quality is not good ( Quality = 31) and the timing to buy is ...(Sign In to See)...

Loading chart...

31 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROE is relatively low.
ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
Historical ROE is relatively low
ROE is decreasing significantly
Acceleration of ROA growth rate is below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...

Quality Factors

39%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	N/A
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	0.87
PBV / Sector	42.98 / -101.57
Earning Per Share	-0.23

PE / Sector	N/A / 31.23
PEG or PE/Growth / Sector	N/A / 0.40
Average 1M Daily Value	1.58 M GREAT
Average 1W Daily Value	0.94 M GREAT

Timing Factors

28%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

39%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

43%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-876.72 / 20.50
NPM Average (%) / Sector	-4,045.12 / -15.37
NPM Change Average (%) / Sector	-37.09 / 7.34
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-132.07 / 39.11
ROA Average (%) / Sector	-157.93 / 5.58
ROA Change Average (%) / Sector	-5.66 / 104.50
ROE (%) / Sector	-1,125.28 / -166.42
ROE Average (%) / Sector	-93.01 / -16.93
ROE Change Average (%) / Sector	-274.29 / -500.08
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.43
Dividend Average (%) / Sector	N/A / 1.85
Dividend Change Average (%) / Sector	N/A / 3.44

Registration Details

Analyze Date	2026-08-01 08:00:08
Symbol	LUCD
Name	LUCID DIAGNOSTICS INC
Sector	Healthcare >> Medical Devices
Market	NASDAQ
Listed Shares	190.77 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	171.92 / 20,104.97

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 360 Madison Avenue, New York, NY, United States, 10017

Phone: 917 813 1828

Website: https://www.luciddx.com

Employees: 82

Sector: Healthcare >> Medical Devices

Description: Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States. It focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. The company's flagship product, the EsoGuard Esophageal DNA Test performed on samples collected with the EsoCheck Esophageal Cell collection device, a testing tool with the goal of preventing EAC deaths through early detection of esophageal precancer in at-risk GERD patients. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. operates as a subsidiary of PAVmed Inc.